We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+12.8%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.21B
AUM Growth
-$296M
Cap. Flow
-$592M
Cap. Flow %
-18.42%
Top 10 Hldgs %
43.24%
Holding
304
New
89
Increased
36
Reduced
82
Closed
88

Top Buys

Rank Stock Value
1
ATAI icon
AtaiBeckley Inc
ATAI
+$25.3M
2
AGL icon
Agilon Health
AGL
+$13.5M
3
LLY icon
Eli Lilly
LLY
+$13.2M
4
PRVA icon
Privia Health
PRVA
+$12.8M
5
LNTH icon
Lantheus
LNTH
+$12.3M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$23.9M
2
VCEL icon
Vericel Corp
VCEL
+$20.8M
3
ALGN icon
Align Technology
ALGN
+$19M
4
SIBN icon
SI-BONE Inc
SIBN
+$17.5M
5
STAA icon
STAAR Surgical
STAA
+$14.6M

Sector Composition

Rank Sector Weight
1 Healthcare 34.64%
2 Industrials 1.41%
3 Materials 0.54%
4 Financials 0.48%
5 Consumer Staples 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CUTR
51
CALL
DELISTED
Cutera, Inc.
CUTR
$14.4M 0.45%
+292,700
New +$10.7M
GDX icon
52
PUT
VanEck Gold Miners ETF
GDX
$27.5B
$14.3M 0.44%
+195,100
New +$7.13M
ICUI icon
53
CALL
ICU Medical
ICUI
$4.55B
$14.1M 0.44%
68,700
+20,900
+44% +$4.3M
CMIIU
54
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$14.1M 0.44%
1,045,043
+7,180
+0.7% +$95.6K
STXS icon
55
Stereotaxis
STXS
$145M
$14M 0.44%
1,452,346
-174,187
-11% -$1.37M
SDGR icon
56
Schrodinger
SDGR
$1.4B
$13.5M 0.42%
178,099
-2,497
-1% -$181K
SYK icon
57
PUT
Stryker
SYK
$134B
$13M 0.4%
+50,000
New +$12.8M
TXG icon
58
PUT
10x Genomics
TXG
$7.62B
$12.7M 0.4%
+65,000
New +$11.8M
TXG icon
59
10x Genomics
TXG
$7.62B
$12.7M 0.39%
64,637
-6,067
-9% -$1.1M
ADPT icon
60
Adaptive Biotechnologies
ADPT
$4.04B
$12.4M 0.39%
303,032
+46,338
+18% +$1.8M
TELA icon
61
TELA Bio
TELA
$35.4M
$12.2M 0.38%
757,524
+336,322
+80% +$4.61M
QGEN icon
62
PUT
Qiagen
QGEN
$8.81B
$12.1M 0.38%
+235,764
New +$12.2M
PSNL icon
63
Personalis
PSNL
$1.5B
$12M 0.37%
475,008
-73,044
-13% -$1.67M
PFE icon
64
PUT
Pfizer
PFE
$152B
$11.7M 0.37%
+300,000
New +$11.7M
DXCM icon
65
DexCom
DXCM
$33.8B
$11.2M 0.35%
105,276
-1,692
-2% -$162K
IVC
66
DELISTED
Invacare Corporation
IVC
$11M 0.34%
1,360,955
-467,140
-26% -$3.89M
CDXS icon
67
Codexis
CDXS
$159M
$11M 0.34%
483,967
+3,032
+0.6% +$65.7K
INOV
68
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$10.9M 0.34%
320,000
+16,500
+5% +$510K
DXCM icon
69
PUT
DexCom
DXCM
$33.8B
$10.7M 0.33%
100,000
-170,000
-63% -$16.3M
PROF
70
Profound Medical
PROF
$254M
$10.5M 0.33%
644,273
-127,320
-17% -$2.37M
MSON
71
DELISTED
Misonix Inc
MSON
$10.5M 0.33%
472,216
-32,541
-6% -$664K
BIIB icon
72
CALL
Biogen
BIIB
$30.1B
$10.4M 0.32%
+30,000
New +$9.09M
OLK
73
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$10M 0.31%
291,278
-82,022
-22% -$2.82M
TALK icon
74
Talkspace
TALK
$869M
$10M 0.31%
1,205,869
+397,780
+49% +$3.87M
APYX icon
75
Apyx Medical
APYX
$127M
$9.82M 0.31%
952,045
-6,443
-0.7% -$63.8K
1 2
3
4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Pura Vida Investments held 304 positions worth $3.21B, down 8.4% from $3.51B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments withdrew a net $592M in Q2 2021, closing 88 positions and reducing 82 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $23.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

Against the trend, Pura Vida Investments opened a new position in AtaiBeckley Inc worth $23.2M.

  • Pura Vida Investments's largest Q2 2021 buy was AtaiBeckley Inc: 1,371,824 shares worth $23.2M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q2 2021, an estimated $9.15M increase.
  • Pura Vida Investments's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $14.6M.
  • Pura Vida Investments fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $23.9M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $3.21B portfolio in Q2 2021.
  • Pura Vida Investments opened 89 new positions and closed 88 in Q2 2021.
  • Pura Vida Investments's portfolio value fell 8.4% quarter-over-quarter to $3.21B.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.